value frameworks

Quality Outlook

Beyond Face Value: Why Indirect Benefits of Cancer Care Matter

05/27/2020

Tom Valuck, MD, JD, and colleagues shed light on the value of indirect benefits of effective cancer care and challenges of measuring such benefits, including insufficient data and patient-focused measures.

Tom Valuck, MD, JD, and...

05/27/2020

Journal of Clinical Pathways

News

Cost-Benefit Analysis Shows Difference in Price, Clinical Benefit of Cancer Drugs in US, Europe

05/26/2020

A cost-benefit analysis published in The Lancet Oncology (May 2020;21[5]:664-670) compared the prices and clinical benefit of cancer drugs in the US vs Europe. Both the US and European countries are faced with the...

A...

05/26/2020

Journal of Clinical Pathways

Perspectives

Advocating for New Patient-Centered Tools for Value-Based Treatment Choices in Oncology

03/13/2019

Jalpa A Doshi, PhD

Ellen Miller-Sonet, MBA, JD

Justin T Puckett

Henry A Glick, PhD

Abstract: The cost of medical drugs continues to increase, and costs of novel therapies for oncology are particularly expensive—for patients as well as health systems in general. Many health care stakeholders are...

...

03/13/2019

Journal of Clinical Pathways

Research in Review

Benefits and Shortcomings of Oncology Value Frameworks for Payers

08/03/2017

JCP Editors

Multiple areas have been identified where oncology value frameworks can be revised in order to increase their utility to payers, according to a study in the Journal of Managed Care & Specialty Pharmacy (June...

...

08/03/2017

Journal of Clinical Pathways